Suppr超能文献

丙型肝炎病毒核心蛋白抑制1型人类免疫缺陷病毒复制。

Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication.

作者信息

Srinivas R V, Ray R B, Meyer K, Ray R

机构信息

Division of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

出版信息

Virus Res. 1996 Dec;45(2):87-92. doi: 10.1016/s0168-1702(96)01361-5.

Abstract

We previously demonstrated that hepatitis C virus (HCV) core protein is a strong repressor of human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) basal transcription. In this study, we have localized the HCV core protein-response domain to a region between nucleotides -65 and +3 within the HIV-LTR. Thus, neither the upstream negative regulatory elements, or binding sites for various transcription factors (e.g. NF-kappa B, USF-1, IL2/IL-2R) nor the downstream TAR regions were involved in HCV core-mediated repression. HCV core protein mediated repression of the basal transcriptional activity of HIV-1 LTR was abrogated by the Tat protein. Furthermore, HeLa-T4 cells expressing HCV core protein showed inhibition of HIV-1 replication after acute infection with cell-free HIV. A similar observation was also noted in CD4+ and CD4-lymphocytic cell lines cotransfected with an infectious molecular clone of HIV-1 and the HCV core protein expression vector. Thus, a repression of basal transcription prior to the accumulation of threshold levels of Tat protein appears to restrict HIV-1 transcription and modulate viral replication.

摘要

我们先前证明丙型肝炎病毒(HCV)核心蛋白是人类免疫缺陷病毒1型(HIV-1)长末端重复序列(LTR)基础转录的强抑制剂。在本研究中,我们已将HCV核心蛋白反应域定位到HIV-LTR内核苷酸-65至+3之间的区域。因此,上游负调控元件或各种转录因子(如NF-κB、USF-1、IL2/IL-2R)的结合位点以及下游TAR区域均未参与HCV核心介导的抑制作用。Tat蛋白可消除HCV核心蛋白介导的HIV-1 LTR基础转录活性的抑制。此外,表达HCV核心蛋白的HeLa-T4细胞在无细胞HIV急性感染后显示出HIV-1复制受到抑制。在用HIV-1感染性分子克隆和HCV核心蛋白表达载体共转染的CD4+和CD4淋巴细胞系中也观察到类似现象。因此,在Tat蛋白达到阈值水平积累之前对基础转录的抑制似乎会限制HIV-1转录并调节病毒复制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验